Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
Clinical trial NCT05116072 · RECRUITING
Trial details
- NCT number
- NCT05116072
- Sponsor
- University Hospital, Lille
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-20
- Primary completion
- 2028-02-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.